Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B.

Developments in biologicals

Volumn 104, Issue , 2000, Pages 115-119

  Swain, W E ^a   Heydenburg Fuller, D ^a   Wu, M S ^a   Barr, L J ^a   Fuller, J T ^a   Culp, J ^a   Burkholder, J ^a   Dixon, R M ^a   Widera, G ^a   Vessey, R ^a   Roy, M J ^a  

^a PowderJect Vaccines Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ANIMAL; ARTICLE; BIOLISTIC TRANSFORMATION; BIOSYNTHESIS; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG TOLERANCE; GENETICS; HAPLORHINI; HUMAN; IMMUNOLOGY; INSTRUMENTATION; METHODOLOGY; PHASE 1 CLINICAL TRIAL; SWINE;

ANIMALS; BIOLISTICS; DRUG TOLERANCE; HAPLORHINI; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; SWINE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0034578088     PISSN: 14246074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)